A Study Evaluating the Efficacy and Safety of Bevacizumab in Combination With Chemotherapy in Untreated Metastatic Breast Cancer (RIBBON 1)
Clinical trial NCT00262067 · UNKNOWN
Trial details
- NCT number
- NCT00262067
- Sponsor
- Genentech, Inc.
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 1237
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.